author-photo

Hadi Danaee

Takeda Pharmaceutical Company
Millennium Pharmaceuticals

40

Papers

762

Citations

Citation Trend

Filter By

Papers (40) Sort By

Journal Conference Others

Preclinical characterization of dostarlimab, a therapeutic anti-PD-1 antibody with potent activity to enhance immune function in in vitro cellular assays and in vivo animal models.

2021 mAbs
Show All
- Source
- Cite
- Save
Citations (0)
Safety and efficacy of anti-PD-1 antibody dostarlimab in patients (pts) with mismatch repair deficient (dMMR) GI cancers.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Abstract LB-226: Exosomal liquid biopsy reveals mRNA and lincRNA biomarkers in early stage breast cancer patient plasma

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo

2018 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (12)
Abstract B050: Evaluation of TAK-264, a novel antibody-drug conjugate in pancreatic cancer cell lines and patient-derived xenograft models

2018 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft Models

2018
Show All
- Source
- Cite
- Save
Citations (3)
Abstract 4535: Automated image analysis algorithm development for cell surface-binding therapeutic agent target & its comparison to manual pathology scoring

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-label, Non-randomized Phase 1 Study.

2017 Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (1)
A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C

2017 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (18)
Aurora A Functional Single Nucleotide Polymorphism (SNP) Correlates With Clinical Outcome in Patients With Advanced Solid Tumors Treated With Alisertib, an Investigational Aurora A Kinase Inhibitor

2017 EBioMedicine
Show All
- Source
- Cite
- Save
Citations (13)